29245312 32823651 29299820 32553750 32946040 34365544 33492612 34647152 32236778 29404893 31040912 31471054 34758866 35061210 31191457 33393372 34090476 33312158 31640258 31112312 30020466 28826822 32445029 34447484 34493834 33427689 35106739 3501186 - Search Results

Year	Number of Results
2017	3
2018	6
2019	16
2020	26
2021	19
2022	7

1

Detection of programmed death ligand 1 protein and CD8+ lymphocyte infiltration in plurihormonal pituitary adenomas: A case report and review of the literatures.

Wang P, Wang T, Yang Y, Yu C, Liu N, Yan C. Wang P, et al. Medicine (Baltimore). 2017 Dec;96(49):e9056. doi: 10.1097/MD.0000000000009056. Medicine (Baltimore). 2017. PMID: 29245312 Free PMC article. Review.

2

Immunotherapy in Corticotroph and Lactotroph Aggressive Tumors and Carcinomas: Two Case Reports and a Review of the Literature.

Duhamel C, Ilie MD, Salle H, Nassouri AS, Gaillard S, Deluche E, Assaker R, Mortier L, Cortet C, Raverot G. Duhamel C, et al. J Pers Med. 2020 Aug 13;10(3):88. doi: 10.3390/jpm10030088. J Pers Med. 2020. PMID: 32823651 Free PMC article.

3

Malignant transformation in non-functioning pituitary adenomas (pituitary carcinoma).

Lenders N, McCormack A. Lenders N, et al. Pituitary. 2018 Apr;21(2):217-229. doi: 10.1007/s11102-017-0857-z. Pituitary. 2018. PMID: 29299820 Review.

4

The tumour microenvironment of pituitary neuroendocrine tumours.

Marques P, Grossman AB, Korbonits M. Marques P, et al. Front Neuroendocrinol. 2020 Jul;58:100852. doi: 10.1016/j.yfrne.2020.100852. Epub 2020 Jun 15. Front Neuroendocrinol. 2020. PMID: 32553750 Review.

5

The role of the tumour microenvironment in the angiogenesis of pituitary tumours.

Marques P, Barry S, Carlsen E, Collier D, Ronaldson A, Dorward N, Grieve J, Mendoza N, Nair R, Muquit S, Grossman AB, Korbonits M. Marques P, et al. Endocrine. 2020 Dec;70(3):593-606. doi: 10.1007/s12020-020-02478-z. Epub 2020 Sep 18. Endocrine. 2020. PMID: 32946040 Free PMC article.

6

Aggressive pituitary neuroendocrine tumors: current practices, controversies, and perspectives, on behalf of the EANS skull base section.

Ng S, Messerer M, Engelhardt J, Bruneau M, Cornelius JF, Cavallo LM, Cossu G, Froelich S, Meling TR, Paraskevopoulos D, Schroeder HWS, Tatagiba M, Zazpe I, Berhouma M, Daniel RT, Laws ER, Knosp E, Buchfelder M, Dufour H, Gaillard S, Jacquesson T, Jouanneau E. Ng S, et al. Acta Neurochir (Wien). 2021 Nov;163(11):3131-3142. doi: 10.1007/s00701-021-04953-6. Epub 2021 Aug 8. Acta Neurochir (Wien). 2021. PMID: 34365544 Review.

7

Immune profiling of pituitary tumors reveals variations in immune infiltration and checkpoint molecule expression.

Mei Y, Bi WL, Agolia J, Hu C, Giantini Larsen AM, Meredith DM, Al Abdulmohsen S, Bale T, Dunn GP, Abedalthagafi M, Dunn IF. Mei Y, et al. Pituitary. 2021 Jun;24(3):359-373. doi: 10.1007/s11102-020-01114-3. Epub 2021 Jan 25. Pituitary. 2021. PMID: 33492612

8

The intestinal flora of patients with GHPA affects the growth and the expression of PD-L1 of tumor.

Nie D, Fang Q, Cheng J, Li B, Li M, Wang H, Li C, Gui S, Zhang Y, Zhao P. Nie D, et al. Cancer Immunol Immunother. 2022 May;71(5):1233-1245. doi: 10.1007/s00262-021-03080-6. Epub 2021 Oct 13. Cancer Immunol Immunother. 2022. PMID: 34647152 Free PMC article.

9

In silico analysis of the immunological landscape of pituitary adenomas.

Yeung JT, Vesely MD, Miyagishima DF. Yeung JT, et al. J Neurooncol. 2020 May;147(3):595-598. doi: 10.1007/s11060-020-03476-x. Epub 2020 Mar 31. J Neurooncol. 2020. PMID: 32236778 Free PMC article.

10

Pathogenesis of non-functioning pituitary adenomas.

Zatelli MC. Zatelli MC. Pituitary. 2018 Apr;21(2):130-137. doi: 10.1007/s11102-018-0874-6. Pituitary. 2018. PMID: 29404893 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results